Company research
Calithera Biosciences, Inc.
CIK 1496671Updated Sep 24, 2026
SecurityCALA · OTC · equity
CALA price & chart
Loading TradingView…
OTC:CALA on TradingView ↗In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2022 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 28,676,000Source | 64,756,000Source | 125,587,000Source | 168,768,000Source |
| Property, Plant and Equipment, NetUSD | 434,000Source | 556,000Source | 690,000Source | 992,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 25,451,000Source | 59,537,000Source | 107,146,000Source | 60,437,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | — | — | 1,541,000Source | 482,000Source |
| Assets, CurrentUSD | 26,624,000Source | 61,452,000Source | 118,703,000Source | 159,796,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 1,173,000Source | 1,915,000Source | 2,011,000Source | 1,953,000Source |
| Operating Lease, Right-of-Use AssetUSD | 1,348,000Source | 2,478,000Source | 5,754,000Source | 7,260,000Source |
| Other Assets, NoncurrentUSD | — | — | — | 280,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 8,284,000Source | 15,672,000Source | 23,216,000Source | 26,342,000Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 22,342,000Source | — | — | — |
| Common Stock, Value, IssuedUSD | — | 8,000Source | 7,000Source | 6,000Source |
| Retained Earnings (Accumulated Deficit)USD | -512,616,000Source | -491,326,000Source | -376,238,000Source | -286,101,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | — | — | 3,000Source | 42,000Source |
| Stockholders' Equity Attributable to ParentUSD | 20,392,000Source | 8,382,000Source | 102,371,000Source | 142,426,000Source |
| Additional Paid in Capital, Common StockUSD | 510,666,000Source | 499,700,000Source | 478,599,000Source | 428,479,000Source |
| Liabilities and EquityUSD | 28,676,000Source | 64,756,000Source | 125,587,000Source | 168,768,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 7,390,000Source | 14,006,000Source | 18,401,000Source | 19,624,000Source |
| Operating Lease, Liability, CurrentUSD | 1,530,000Source | 1,374,000Source | 1,903,000Source | 1,478,000Source |
| Accounts Payable, CurrentUSD | 732,000Source | 3,650,000Source | 1,994,000Source | 2,052,000Source |
| Operating Lease, Liability, NoncurrentUSD | 136,000Source | 1,666,000Source | 4,815,000Source | 6,718,000Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | — | — | — | 17,572,000Source |
| Deferred Tax Liabilities, NetUSD | 283,000Source | 520,000Source | 1,209,000Source | 1,525,000Source |
cash flow · annual statements
| Line item | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | -39,650,000Source | -115,088,000Source | -90,137,000Source | -89,860,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 300,000Source | 300,000Source | 364,000Source | 479,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 4,030,000Source | 10,264,000Source | 8,060,000Source | 6,466,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | — | -1,541,000Source | 1,059,000Source | -1,515,000Source |
| Increase (Decrease) in Accounts PayableUSD | -2,918,000Source | 1,656,000Source | -58,000Source | 816,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -43,608,000Source | -66,300,000Source | -84,312,000Source | -78,745,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -133,000Source | 7,853,000Source | 88,960,000Source | -10,784,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 133,000Source | 147,000Source | 61,000Source | 7,000Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 9,655,000Source | 10,668,000Source | 42,061,000Source | 98,908,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -34,086,000Source | -47,779,000Source | 46,709,000Source | 9,379,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 25,700,000Source | 59,800,000Source | — | — |
| Additional Financial Items | ||||
| Debt Securities, Available-for-sale, Realized Gain (Loss)USD | 0Source | 0Source | — | — |
| DepreciationUSD | 255,000Source | 280,000Source | 364,000Source | 479,000Source |
| General and Administrative ExpenseUSD | 13,541,000Source | 20,853,000Source | 20,372,000Source | 16,605,000Source |
| Income Tax Expense (Benefit)USD | 0Source | 0Source | 0Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | -39,650,000Source | -115,088,000Source | -90,137,000Source | -89,860,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -21,290,000Source | — | — | — |
| Operating ExpensesUSD | 42,074,000Source | 125,183,000Source | 91,387,000Source | 92,895,000Source |
| Other Nonoperating Income (Expense)USD | 2,424,000Source | — | — | — |
| Proceeds from Issuance of Common StockUSD | 1,137,000Source | 10,664,000Source | 7,397,000Source | 43,926,000Source |
income statement · annual statements
| Line item | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Total RevenueUSD | — | 9,750,000Source | — | — |
| Operating Income (Loss)USD | -42,074,000Source | -115,433,000Source | -91,387,000Source | -92,895,000Source |
| Other Nonoperating Income (Expense)USD | 2,424,000Source | — | — | — |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -39,650,000Source | -115,088,000Source | — | — |
| Income Tax Expense (Benefit)USD | 0Source | 0Source | 0Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | -39,650,000Source | -115,088,000Source | -90,137,000Source | -89,860,000Source |
| Earnings Per Share, BasicUSD per share | -4.6Source | — | — | — |
| Earnings Per Share, DilutedUSD per share | -7.94Source | — | — | — |
| Weighted Average Number of Shares Outstanding, Basicshares | 4,633,000Source | — | — | — |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 4,992,000Source | — | — | — |
| Additional Financial Items | ||||
| General and Administrative ExpenseUSD | 13,541,000Source | 20,853,000Source | 20,372,000Source | 16,605,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | -39,650,000Source | -115,088,000Source | -90,137,000Source | -89,860,000Source |
| Interest and Other IncomeUSD | 477,000Source | 345,000Source | 1,250,000Source | 3,035,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -21,290,000Source | — | — | — |
| Operating ExpensesUSD | 42,074,000Source | 125,183,000Source | 91,387,000Source | 92,895,000Source |
| Research and Development ExpenseUSD | — | — | 71,015,000Source | 76,290,000Source |